• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

那他珠单抗诱导的皮肤类肉瘤样反应。

Natalizumab induced cutaneous sarcoidosis-like reaction.

机构信息

Department of Neurology, Cork University Hospital, Ireland.

Department of Histopathology, Cork University Hospital, Ireland.

出版信息

J Neuroimmunol. 2019 Aug 15;333:476955. doi: 10.1016/j.jneuroim.2019.04.015. Epub 2019 Apr 30.

DOI:10.1016/j.jneuroim.2019.04.015
PMID:31108403
Abstract

We present a case of a drug-induced sarcoidosis -like reaction (DISR) occurring following initiation of Natalizumab for multiple sclerosis. The reaction was purely cutaneous, and disappeared following drug withdrawal. We highlight this case to the practicing neurologists, with warning to be wary of a new rash on immunomodulatory therapies.

摘要

我们报告了一例在使用那他珠单抗治疗多发性硬化症后发生的药物诱导的类肉瘤样反应(DISR)。该反应为单纯皮肤型,停药后消失。我们向神经内科医生强调了这种情况,并警告他们在免疫调节治疗中要警惕新出现的皮疹。

相似文献

1
Natalizumab induced cutaneous sarcoidosis-like reaction.那他珠单抗诱导的皮肤类肉瘤样反应。
J Neuroimmunol. 2019 Aug 15;333:476955. doi: 10.1016/j.jneuroim.2019.04.015. Epub 2019 Apr 30.
2
Evolution of MRI appearances due to progressive multifocal leucoencephalopathy following natalizumab treatment for multiple sclerosis.Natalizumab治疗多发性硬化症后因进行性多灶性白质脑病导致的MRI表现演变
BMJ Case Rep. 2015 Apr 15;2015:bcr2015210305. doi: 10.1136/bcr-2015-210305.
3
Localized sporotrichosis during natalizumab treatment in Multiple Sclerosis.多发性硬化症患者接受那他珠单抗治疗期间发生的局限性孢子丝菌病。
Mult Scler Relat Disord. 2020 Jun;41:102029. doi: 10.1016/j.msard.2020.102029. Epub 2020 Feb 26.
4
Cyclical suicidal ideation following natalizumab infusion for multiple sclerosis.natalizumab输注治疗多发性硬化症后出现周期性自杀观念
Aust N Z J Psychiatry. 2015 Jul;49(7):668-9. doi: 10.1177/0004867415572414. Epub 2015 Feb 16.
5
Refractory epilepsy following natalizumab associated PML.抗纳武单抗相关进行性多灶性白质脑病后出现耐药性癫痫。
Mult Scler Relat Disord. 2018 Feb;20:1-2. doi: 10.1016/j.msard.2017.12.004. Epub 2017 Dec 13.
6
Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab.服用芬戈莫德或那他珠单抗的多发性硬化症患者中的登革热
Mult Scler Relat Disord. 2016 Mar;6:64-65. doi: 10.1016/j.msard.2016.01.005. Epub 2016 Jan 28.
7
Natalizumab exposure during pregnancy in multiple sclerosis: a systematic review.多发性硬化症患者孕期使用那他珠单抗的系统评价
J Neurol Sci. 2019 Jan 15;396:202-205. doi: 10.1016/j.jns.2018.11.026. Epub 2018 Nov 22.
8
[Natalizumab can induce progressive multifocal leucoencephalopathy].那他珠单抗可诱发进行性多灶性白质脑病。
Ugeskr Laeger. 2014 Aug 25;176(35).
9
Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology.那他珠单抗治疗多发性硬化症:转化神经免疫学影响的一个典型案例
J Immunol. 2017 Feb 15;198(4):1381-1386. doi: 10.4049/jimmunol.1601358.
10
Severe CNS inflammation after discontinuation of natalizumab and start of daclizumab successfully treated with alemtuzumab.纳武单抗治疗终止后出现严重中枢神经系统炎症,改用达利珠单抗治疗成功。
Mult Scler Relat Disord. 2018 May;22:87-89. doi: 10.1016/j.msard.2018.03.021. Epub 2018 Mar 29.

引用本文的文献

1
Drug-Induced Sarcoid-like Reactions Associated to Targeted Therapies and Biologic Agents.与靶向治疗和生物制剂相关的药物诱导的结节病样反应。
Diagnostics (Basel). 2025 Jun 29;15(13):1658. doi: 10.3390/diagnostics15131658.
2
Cutaneous Adverse Reactions Associated with Monoclonal Antibodies Treatment in Multiple Sclerosis: Case Reports and Short Literature Review.多发性硬化症中与单克隆抗体治疗相关的皮肤不良反应:病例报告及文献综述
J Clin Med. 2022 Jun 27;11(13):3702. doi: 10.3390/jcm11133702.
3
Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.
在用司库奇尤单抗治疗银屑病关节炎期间出现的结节病。
BMJ Case Rep. 2021 Feb 22;14(2):e240615. doi: 10.1136/bcr-2020-240615.
4
Granulomatous Cutaneous Drug Eruptions: A Systematic Review.肉芽肿性皮肤药物反应:系统综述。
Am J Clin Dermatol. 2021 Jan;22(1):39-53. doi: 10.1007/s40257-020-00566-4.